Charles W.M. Roberts, MD, PhD; Eduardo M. Sotomayor, MD; and Parker B. Antin, PhD, are highlighted.
Charles W. M. Roberts, MD, PhD, has been named executive vice president of St. Jude Children's Research Hospital and director of the St. Jude Comprehensive Cancer Center in Memphis, TN. Succeeding Richard Gilbertson, MD, PhD, Roberts assumed his new role on September 1. Previously, he served as deputy chief scientific officer at Dana-Farber Cancer Institute in Boston, MA, and as a pediatric oncologist at Boston Children's Hospital. He is a leader in the field of cancer epigenetics, and his research has provided insights into the central role of chromatin remodeling in germline and sporadic cancers.
Eduardo M. Sotomayor, MD, became the inaugural director of the George Washington University Cancer Center (GWCC) in Washington, DC, in July. The center incorporates all cancer-related activities, including those of the affiliated GW Cancer Institute. One of Sotomayor's top priorities will be to attain NCI designation within the next 10 years. Prior to joining GWCC, he served as chair of the Department of Hematology at the Moffitt Cancer Center and Research Institute in Tampa, FL. His research focuses on immunobiology and immunotherapy of B-cell malignancies.
Parker B. Antin, PhD, associate dean for research in the College of Agriculture and Life Sciences at the University of Arizona in Tucson, began a 1-year term as president of the Federation of American Societies for Experimental Biology (FASEB) in July. His research, which incorporates developmental biology, genomics, and bioinformatics, investigates vertebrate development with an emphasis on cardiovascular development and disease.
For more news on cancer research, visit Cancer Discovery online at http://CDnews.aacrjournals.org.